These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72. Lipid level alterations in the Helsinki Heart Study. JAMA; 1989 Jan; 261(4):554-5. PubMed ID: 2909790 [No Abstract] [Full Text] [Related]
73. [Changes in serum lipid levels in coronary heart disease with energy stagnancy and blood stasis]. Xu QY Zhong Xi Yi Jie He Za Zhi; 1985 May; 5(5):265-6, 258. PubMed ID: 3159492 [No Abstract] [Full Text] [Related]
74. Serum HDL cholesterol: should it be routinely measured? Dimmitt SB; Watts GF Med J Aust; 1995 Oct; 163(8):425-7. PubMed ID: 7476614 [TBL] [Abstract][Full Text] [Related]
75. Lipoprotein changes during acute coronary syndromes. Batalla A; Hevia S; Sieres M; Raviña T Am J Cardiol; 2002 Sep; 90(5):572. PubMed ID: 12208432 [No Abstract] [Full Text] [Related]
76. Quality measurement issues in heart disease in women. Judelson DR Womens Health Issues; 1999; 9(5):241-8; discussion 248-9. PubMed ID: 10560322 [TBL] [Abstract][Full Text] [Related]
77. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators. Miettinen TA; Gylling H; Strandberg T; Sarna S BMJ; 1998 Apr; 316(7138):1127-30. PubMed ID: 9552949 [No Abstract] [Full Text] [Related]
79. Iron status and the risk of coronary heart disease. Sempos CT; Looker AC Nutr Metab Cardiovasc Dis; 1999 Dec; 9(6):294-303. PubMed ID: 10765522 [No Abstract] [Full Text] [Related]